MCL1 is an anti-apoptotic member of the BCL2 family and is known to be focally amplified in about 10.9% of cancers across multiple tissue types (e.g. breast cancer, lung cancer, etc.)and to increase tumor cell survival [21]. This evidence concerns the gene BCL2 and neoplasm.